Recent

% | $
Quotes you view appear here for quick access.

Elan Corporation, plc Message Board

  • havenger2001 havenger2001 Feb 7, 2013 11:57 PM Flag

    ELAN's Alzheimer's Disease Research pipeline

    ELN005 is a small molecule designed against Alzheimer's disease. This is a separate program different from Bapineuzumab, AAB-003, ACC-001 (sold to J&J):
    Clinical trial will be due by Dec 2013:
    ALZHEIMER'S DISEASE
    ELND005
    Beta Secretase Research

    ALZHEIMER'S DISEASE - AGITATION /AGGRESSION
    ELND005

    BIPOLAR DISORDER
    ELND005

    PARKINSON'S DISEASE
    Parkinson's Research

    Sentiment: Strong Buy

 
ELN
0.00(0.00%)